Degarelix acetate
Jump to navigation
Jump to search
| Degarelix acetate | |
|---|---|
| Term | Degarelix acetate |
| Short definition | degarelix acetate - (pronounced) (DEH-guh-REH-lix A-seh-tayt) drug used to treat advanced prostate cancer. Degarelix acetate binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
degarelix acetate - (pronounced) (DEH-guh-REH-lix A-seh-tayt) drug used to treat advanced prostate cancer. Degarelix acetate binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. This causes the testicles to stop producing testosterone. Degarelix acetate can stop the growth of cancer cells that need testosterone to grow. It's a type of GnRH antagonist. Also called firmagon
External links
- Medical encyclopedia article on Degarelix acetate
- Wikipedia's article - Degarelix acetate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski